

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.13555792 |
| 2 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 5.00253291 |
| 3 | macrophage activation involved in immune response (GO:0002281) | 4.88602876 |
| 4 | detection of molecule of bacterial origin (GO:0032490) | 4.84785966 |
| 5 | negative regulation of interleukin-12 production (GO:0032695) | 4.83672503 |
| 6 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.80178082 |
| 7 | negative regulation of cell killing (GO:0031342) | 4.80178082 |
| 8 | T cell migration (GO:0072678) | 4.53364039 |
| 9 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.49979483 |
| 10 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.43353698 |
| 11 | regulation of isotype switching to IgG isotypes (GO:0048302) | 4.41739594 |
| 12 | detection of other organism (GO:0098543) | 4.38506940 |
| 13 | activated T cell proliferation (GO:0050798) | 4.34974784 |
| 14 | negative T cell selection (GO:0043383) | 4.27721644 |
| 15 | leukocyte aggregation (GO:0070486) | 4.26133558 |
| 16 | cellular extravasation (GO:0045123) | 4.16946654 |
| 17 | negative thymic T cell selection (GO:0045060) | 4.12905752 |
| 18 | positive regulation of T cell cytokine production (GO:0002726) | 4.12110478 |
| 19 | microglial cell activation (GO:0001774) | 4.09384781 |
| 20 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.09242948 |
| 21 | detection of external biotic stimulus (GO:0098581) | 4.06525400 |
| 22 | neutrophil activation involved in immune response (GO:0002283) | 3.99261158 |
| 23 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.96930381 |
| 24 | response to host immune response (GO:0052572) | 3.96930381 |
| 25 | regulation of T cell tolerance induction (GO:0002664) | 3.93168628 |
| 26 | neutrophil mediated immunity (GO:0002446) | 3.89511061 |
| 27 | detection of bacterium (GO:0016045) | 3.86846529 |
| 28 | germinal center formation (GO:0002467) | 3.84463603 |
| 29 | macrophage activation (GO:0042116) | 3.81976634 |
| 30 | detection of biotic stimulus (GO:0009595) | 3.77078524 |
| 31 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.76692081 |
| 32 | interferon-gamma production (GO:0032609) | 3.74820589 |
| 33 | positive regulation by symbiont of host defense response (GO:0052509) | 3.74253246 |
| 34 | modulation by symbiont of host defense response (GO:0052031) | 3.74253246 |
| 35 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.74253246 |
| 36 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.74253246 |
| 37 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.74253246 |
| 38 | modulation by symbiont of host immune response (GO:0052553) | 3.74253246 |
| 39 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.73061789 |
| 40 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.71545630 |
| 41 | positive regulation of interleukin-2 production (GO:0032743) | 3.70782492 |
| 42 | NIK/NF-kappaB signaling (GO:0038061) | 3.70391617 |
| 43 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.69513098 |
| 44 | regulation of gamma-delta T cell activation (GO:0046643) | 3.68973222 |
| 45 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.65526291 |
| 46 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.60166531 |
| 47 | response to host (GO:0075136) | 3.60166531 |
| 48 | response to host defenses (GO:0052200) | 3.60166531 |
| 49 | positive thymic T cell selection (GO:0045059) | 3.57428214 |
| 50 | type I interferon signaling pathway (GO:0060337) | 3.56641280 |
| 51 | cellular response to type I interferon (GO:0071357) | 3.56641280 |
| 52 | response to type I interferon (GO:0034340) | 3.56354163 |
| 53 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.55949446 |
| 54 | immunoglobulin mediated immune response (GO:0016064) | 3.52305013 |
| 55 | positive T cell selection (GO:0043368) | 3.51600953 |
| 56 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.50800365 |
| 57 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.50800365 |
| 58 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.50563307 |
| 59 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.49493430 |
| 60 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.47021901 |
| 61 | T-helper 1 type immune response (GO:0042088) | 3.46897330 |
| 62 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.44567872 |
| 63 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.43606795 |
| 64 | tolerance induction (GO:0002507) | 3.43311719 |
| 65 | response to muramyl dipeptide (GO:0032495) | 3.41059587 |
| 66 | response to protozoan (GO:0001562) | 3.39087127 |
| 67 | regulation of chronic inflammatory response (GO:0002676) | 3.35242557 |
| 68 | T cell selection (GO:0045058) | 3.34978525 |
| 69 | positive regulation of humoral immune response (GO:0002922) | 3.33924769 |
| 70 | myeloid leukocyte mediated immunity (GO:0002444) | 3.33847639 |
| 71 | T-helper cell differentiation (GO:0042093) | 3.33695464 |
| 72 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.33695464 |
| 73 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.33647226 |
| 74 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.33500386 |
| 75 | myeloid cell activation involved in immune response (GO:0002275) | 3.32699301 |
| 76 | respiratory burst (GO:0045730) | 3.31839037 |
| 77 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.30563553 |
| 78 | T cell receptor signaling pathway (GO:0050852) | 3.28063786 |
| 79 | positive regulation of isotype switching (GO:0045830) | 3.27479636 |
| 80 | cellular response to interleukin-15 (GO:0071350) | 3.27360715 |
| 81 | alpha-beta T cell activation (GO:0046631) | 3.25314789 |
| 82 | positive regulation of interleukin-17 production (GO:0032740) | 3.24434457 |
| 83 | T cell differentiation involved in immune response (GO:0002292) | 3.22753268 |
| 84 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 3.22753268 |
| 85 | alpha-beta T cell activation involved in immune response (GO:0002287) | 3.22753268 |
| 86 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.22254080 |
| 87 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.21792943 |
| 88 | B cell receptor signaling pathway (GO:0050853) | 3.21359457 |
| 89 | alpha-beta T cell differentiation (GO:0046632) | 3.19888646 |
| 90 | regulation of T cell cytokine production (GO:0002724) | 3.19834201 |
| 91 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.18576759 |
| 92 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.17822728 |
| 93 | T cell costimulation (GO:0031295) | 3.14632495 |
| 94 | thymic T cell selection (GO:0045061) | 3.14428211 |
| 95 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.12058333 |
| 96 | positive regulation of B cell mediated immunity (GO:0002714) | 3.12058333 |
| 97 | lymphocyte costimulation (GO:0031294) | 3.10289275 |
| 98 | negative regulation of T cell mediated immunity (GO:0002710) | 3.09510502 |
| 99 | regulation of tolerance induction (GO:0002643) | 3.09434687 |
| 100 | positive regulation of interferon-beta production (GO:0032728) | 3.04633658 |
| 101 | negative regulation of interleukin-6 production (GO:0032715) | 3.04559083 |
| 102 | regulation of immunoglobulin secretion (GO:0051023) | 3.02733756 |
| 103 | response to interleukin-15 (GO:0070672) | 3.01811996 |
| 104 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.01530029 |
| 105 | positive regulation of interleukin-12 production (GO:0032735) | 3.00447511 |
| 106 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.97660443 |
| 107 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.95483670 |
| 108 | positive regulation of DNA recombination (GO:0045911) | 2.95389148 |
| 109 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.95078751 |
| 110 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.94321351 |
| 111 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.92160577 |
| 112 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.92160577 |
| 113 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.91844338 |
| 114 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.91748876 |
| 115 | positive regulation of B cell differentiation (GO:0045579) | 2.91083428 |
| 116 | positive regulation of tolerance induction (GO:0002645) | 2.90537277 |
| 117 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.90050869 |
| 118 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.89571736 |
| 119 | regulation of isotype switching (GO:0045191) | 2.88657581 |
| 120 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.88247444 |
| 121 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.87750452 |
| 122 | T cell proliferation (GO:0042098) | 2.87120584 |
| 123 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.87045412 |
| 124 | regulation of interferon-alpha production (GO:0032647) | 2.85837049 |
| 125 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 2.85613901 |
| 126 | regulation of regulatory T cell differentiation (GO:0045589) | 2.85563113 |
| 127 | negative regulation of B cell proliferation (GO:0030889) | 2.84896629 |
| 128 | myeloid dendritic cell differentiation (GO:0043011) | 2.83323581 |
| 129 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.83253258 |
| 130 | regulation of interleukin-12 production (GO:0032655) | 2.83093881 |
| 131 | B cell mediated immunity (GO:0019724) | 2.82608911 |
| 132 | leukocyte cell-cell adhesion (GO:0007159) | 2.82231266 |
| 133 | myeloid leukocyte activation (GO:0002274) | 2.82037899 |
| 134 | positive regulation of interferon-alpha production (GO:0032727) | 2.81697331 |
| 135 | positive regulation of type 2 immune response (GO:0002830) | 2.81287646 |
| 136 | regulation of B cell differentiation (GO:0045577) | 2.80181155 |
| 137 | regulation of immunoglobulin mediated immune response (GO:0002889) | 2.79990574 |
| 138 | response to peptidoglycan (GO:0032494) | 2.79075158 |
| 139 | regulation of interleukin-17 production (GO:0032660) | 2.78932330 |
| 140 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.78175261 |
| 141 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.77337399 |
| 142 | * regulation of toll-like receptor signaling pathway (GO:0034121) | 2.76768665 |
| 143 | T cell activation involved in immune response (GO:0002286) | 2.75903696 |
| 144 | cellular response to interferon-beta (GO:0035458) | 2.73995018 |
| 145 | regulation of interleukin-2 production (GO:0032663) | 2.73415835 |
| 146 | natural killer cell activation (GO:0030101) | 2.72984445 |
| 147 | myeloid dendritic cell activation (GO:0001773) | 2.72244086 |
| 148 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.71851560 |
| 149 | positive regulation of interferon-gamma production (GO:0032729) | 2.71191175 |
| 150 | granulocyte activation (GO:0036230) | 2.70990892 |
| 151 | neutrophil activation (GO:0042119) | 2.70191295 |
| 152 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.69988321 |
| 153 | regulation of B cell mediated immunity (GO:0002712) | 2.69690103 |
| 154 | defense response to protozoan (GO:0042832) | 2.68843811 |
| 155 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.68821683 |
| 156 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.68765445 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 8.00885130 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.36696303 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.15907172 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.49288465 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.31621269 |
| 6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.25030552 |
| 7 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 4.15999976 |
| 8 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.44746442 |
| 9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.34429427 |
| 10 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.10243331 |
| 11 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.98764448 |
| 12 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.93736362 |
| 13 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.91559953 |
| 14 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.71685491 |
| 15 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.65023225 |
| 16 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.59644448 |
| 17 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.58427725 |
| 18 | MYB_26560356_Chip-Seq_TH2_Human | 2.56727810 |
| 19 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.51372957 |
| 20 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.35446977 |
| 21 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.20559079 |
| 22 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.19760822 |
| 23 | MAF_26560356_Chip-Seq_TH1_Human | 2.11047569 |
| 24 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.04793427 |
| 25 | MYB_26560356_Chip-Seq_TH1_Human | 2.00536475 |
| 26 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.78013323 |
| 27 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.77257847 |
| 28 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.73925273 |
| 29 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.69237732 |
| 30 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.69237732 |
| 31 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.69237732 |
| 32 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.65543205 |
| 33 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.64689521 |
| 34 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.62383198 |
| 35 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.62317265 |
| 36 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.61751114 |
| 37 | UTX_26944678_Chip-Seq_JUKART_Human | 1.60069706 |
| 38 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.55847873 |
| 39 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.55266496 |
| 40 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.54284391 |
| 41 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.50279691 |
| 42 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.47914235 |
| 43 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.46497691 |
| 44 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.36528925 |
| 45 | GATA1_22025678_ChIP-Seq_K562_Human | 1.34545611 |
| 46 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.33005924 |
| 47 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.30982527 |
| 48 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.30117828 |
| 49 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.29416000 |
| 50 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.27457224 |
| 51 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.26869220 |
| 52 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.21881015 |
| 53 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.21581321 |
| 54 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.19949555 |
| 55 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.18675609 |
| 56 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.17947256 |
| 57 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.17471514 |
| 58 | MAF_26560356_Chip-Seq_TH2_Human | 1.14812841 |
| 59 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.14344130 |
| 60 | SPI1_23127762_ChIP-Seq_K562_Human | 1.10771897 |
| 61 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.10256885 |
| 62 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.09753892 |
| 63 | MYC_22102868_ChIP-Seq_BL_Human | 1.09398298 |
| 64 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05597523 |
| 65 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04642544 |
| 66 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.04547485 |
| 67 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.99465411 |
| 68 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.99397152 |
| 69 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.98947795 |
| 70 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.98672710 |
| 71 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96647808 |
| 72 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.96100399 |
| 73 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.95435704 |
| 74 | GATA3_26560356_Chip-Seq_TH2_Human | 0.91822645 |
| 75 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.91491239 |
| 76 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.88056313 |
| 77 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86264138 |
| 78 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.85136740 |
| 79 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85136740 |
| 80 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.84631788 |
| 81 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.84532761 |
| 82 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83229153 |
| 83 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82687114 |
| 84 | GATA1_19941826_ChIP-Seq_K562_Human | 0.82623385 |
| 85 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.82504132 |
| 86 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.82202246 |
| 87 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82135435 |
| 88 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.82040290 |
| 89 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.80102943 |
| 90 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.79419035 |
| 91 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.74576841 |
| 92 | GATA2_19941826_ChIP-Seq_K562_Human | 0.74332531 |
| 93 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.73707626 |
| 94 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.73444713 |
| 95 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.71705172 |
| 96 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.70220345 |
| 97 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.68869088 |
| 98 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.68502329 |
| 99 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.67198369 |
| 100 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.67177073 |
| 101 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.66100840 |
| 102 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.65973439 |
| 103 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.65914074 |
| 104 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.65548573 |
| 105 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.65188613 |
| 106 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.65059784 |
| 107 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.65057669 |
| 108 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.65047796 |
| 109 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.64833418 |
| 110 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.64582692 |
| 111 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.64471100 |
| 112 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.63961083 |
| 113 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.63892789 |
| 114 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.63218128 |
| 115 | * RXR_22108803_ChIP-Seq_LS180_Human | 0.61542837 |
| 116 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.61482607 |
| 117 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.61338877 |
| 118 | * P300_19829295_ChIP-Seq_ESCs_Human | 0.61024020 |
| 119 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.60427020 |
| 120 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.60335910 |
| 121 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.59884851 |
| 122 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.59625116 |
| 123 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.59382237 |
| 124 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.59059469 |
| 125 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.58502367 |
| 126 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.58140609 |
| 127 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.57169705 |
| 128 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.56967030 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 4.04006692 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.83145725 |
| 3 | MP0009785_altered_susceptibility_to | 3.69636149 |
| 4 | MP0003763_abnormal_thymus_physiology | 3.60550359 |
| 5 | MP0005000_abnormal_immune_tolerance | 3.33401246 |
| 6 | MP0002148_abnormal_hypersensitivity_rea | 3.15383112 |
| 7 | MP0000685_abnormal_immune_system | 3.13624195 |
| 8 | MP0003436_decreased_susceptibility_to | 3.04301735 |
| 9 | MP0001800_abnormal_humoral_immune | 3.02179410 |
| 10 | MP0001790_abnormal_immune_system | 2.99254314 |
| 11 | MP0005387_immune_system_phenotype | 2.99254314 |
| 12 | MP0006082_CNS_inflammation | 2.89739480 |
| 13 | * MP0002723_abnormal_immune_serum | 2.80709949 |
| 14 | * MP0002452_abnormal_antigen_presenting | 2.75240576 |
| 15 | MP0003303_peritoneal_inflammation | 2.74925584 |
| 16 | MP0005025_abnormal_response_to | 2.70873876 |
| 17 | MP0003724_increased_susceptibility_to | 2.64895175 |
| 18 | * MP0001819_abnormal_immune_cell | 2.62393934 |
| 19 | * MP0002420_abnormal_adaptive_immunity | 2.61024409 |
| 20 | MP0004510_myositis | 2.37748603 |
| 21 | MP0002419_abnormal_innate_immunity | 2.37695493 |
| 22 | MP0002006_tumorigenesis | 2.20628716 |
| 23 | * MP0002398_abnormal_bone_marrow | 2.15762648 |
| 24 | MP0002405_respiratory_system_inflammati | 2.14877344 |
| 25 | MP0009333_abnormal_splenocyte_physiolog | 2.12355317 |
| 26 | MP0002166_altered_tumor_susceptibility | 2.06709814 |
| 27 | * MP0000716_abnormal_immune_system | 2.06022626 |
| 28 | MP0004947_skin_inflammation | 2.03953316 |
| 29 | MP0004381_abnormal_hair_follicle | 1.96006366 |
| 30 | MP0008004_abnormal_stomach_pH | 1.92056403 |
| 31 | MP0010155_abnormal_intestine_physiology | 1.88380710 |
| 32 | MP0000703_abnormal_thymus_morphology | 1.60019047 |
| 33 | MP0002009_preneoplasia | 1.58172197 |
| 34 | * MP0002429_abnormal_blood_cell | 1.57275206 |
| 35 | MP0001873_stomach_inflammation | 1.57138520 |
| 36 | MP0000689_abnormal_spleen_morphology | 1.55460263 |
| 37 | MP0002722_abnormal_immune_system | 1.54526847 |
| 38 | MP0001853_heart_inflammation | 1.54493787 |
| 39 | MP0005310_abnormal_salivary_gland | 1.53871909 |
| 40 | MP0003448_altered_tumor_morphology | 1.52539451 |
| 41 | * MP0001845_abnormal_inflammatory_respons | 1.48749152 |
| 42 | MP0009278_abnormal_bone_marrow | 1.45150991 |
| 43 | MP0001533_abnormal_skeleton_physiology | 1.43761371 |
| 44 | MP0005451_abnormal_body_composition | 1.38363798 |
| 45 | MP0002933_joint_inflammation | 1.36773420 |
| 46 | MP0003300_gastrointestinal_ulcer | 1.35411602 |
| 47 | MP0000569_abnormal_digit_pigmentation | 1.35142756 |
| 48 | MP0003075_altered_response_to | 1.34635036 |
| 49 | MP0004883_abnormal_blood_vessel | 1.31931424 |
| 50 | MP0002332_abnormal_exercise_endurance | 1.28005483 |
| 51 | MP0003221_abnormal_cardiomyocyte_apopto | 1.26927242 |
| 52 | MP0002254_reproductive_system_inflammat | 1.25945458 |
| 53 | MP0002277_abnormal_respiratory_mucosa | 1.23907673 |
| 54 | MP0003191_abnormal_cellular_cholesterol | 1.23649212 |
| 55 | MP0005164_abnormal_response_to | 1.22611022 |
| 56 | MP0002998_abnormal_bone_remodeling | 1.21968755 |
| 57 | MP0001851_eye_inflammation | 1.20832427 |
| 58 | MP0003866_abnormal_defecation | 1.18700912 |
| 59 | MP0003656_abnormal_erythrocyte_physiolo | 1.18529360 |
| 60 | MP0005464_abnormal_platelet_physiology | 1.17434830 |
| 61 | MP0004742_abnormal_vestibular_system | 1.15690211 |
| 62 | MP0000920_abnormal_myelination | 1.08535029 |
| 63 | MP0003172_abnormal_lysosome_physiology | 1.07052073 |
| 64 | MP0000778_abnormal_nervous_system | 1.06003416 |
| 65 | * MP0008469_abnormal_protein_level | 1.04831115 |
| 66 | MP0005167_abnormal_blood-brain_barrier | 1.02346343 |
| 67 | MP0000465_gastrointestinal_hemorrhage | 1.01548976 |
| 68 | * MP0009764_decreased_sensitivity_to | 0.98657410 |
| 69 | MP0008057_abnormal_DNA_replication | 0.94697142 |
| 70 | MP0005174_abnormal_tail_pigmentation | 0.93927116 |
| 71 | MP0001545_abnormal_hematopoietic_system | 0.91315722 |
| 72 | MP0005397_hematopoietic_system_phenotyp | 0.91315722 |
| 73 | MP0010352_gastrointestinal_tract_polyps | 0.89587147 |
| 74 | MP0003091_abnormal_cell_migration | 0.88237977 |
| 75 | MP0000858_altered_metastatic_potential | 0.87627119 |
| 76 | MP0004808_abnormal_hematopoietic_stem | 0.86315790 |
| 77 | MP0003453_abnormal_keratinocyte_physiol | 0.84044694 |
| 78 | MP0003136_yellow_coat_color | 0.82103664 |
| 79 | MP0000383_abnormal_hair_follicle | 0.81513415 |
| 80 | MP0005423_abnormal_somatic_nervous | 0.77348629 |
| 81 | MP0000249_abnormal_blood_vessel | 0.73896528 |
| 82 | MP0008995_early_reproductive_senescence | 0.73814932 |
| 83 | MP0000490_abnormal_crypts_of | 0.73466497 |
| 84 | MP0000343_altered_response_to | 0.72066715 |
| 85 | MP0008260_abnormal_autophagy | 0.71857699 |
| 86 | MP0003787_abnormal_imprinting | 0.71226211 |
| 87 | MP0002138_abnormal_hepatobiliary_system | 0.69003569 |
| 88 | MP0002653_abnormal_ependyma_morphology | 0.66839875 |
| 89 | MP0005390_skeleton_phenotype | 0.65452812 |
| 90 | MP0003045_fibrosis | 0.65281448 |
| 91 | MP0002102_abnormal_ear_morphology | 0.65209612 |
| 92 | MP0004484_altered_response_of | 0.64025875 |
| 93 | MP0003183_abnormal_peptide_metabolism | 0.63089053 |
| 94 | MP0003195_calcinosis | 0.60260401 |
| 95 | MP0005645_abnormal_hypothalamus_physiol | 0.60133891 |
| 96 | MP0005076_abnormal_cell_differentiation | 0.58898372 |
| 97 | MP0000015_abnormal_ear_pigmentation | 0.57512837 |
| 98 | MP0004134_abnormal_chest_morphology | 0.54540888 |
| 99 | MP0005166_decreased_susceptibility_to | 0.52877614 |
| 100 | MP0003795_abnormal_bone_structure | 0.52736395 |
| 101 | MP0000604_amyloidosis | 0.52469898 |
| 102 | MP0002396_abnormal_hematopoietic_system | 0.51863847 |
| 103 | MP0002133_abnormal_respiratory_system | 0.51573755 |
| 104 | MP0005388_respiratory_system_phenotype | 0.51573755 |
| 105 | MP0005075_abnormal_melanosome_morpholog | 0.51497054 |
| 106 | MP0005409_darkened_coat_color | 0.51173411 |
| 107 | MP0002132_abnormal_respiratory_system | 0.50299981 |
| 108 | MP0003828_pulmonary_edema | 0.50272815 |
| 109 | MP0003690_abnormal_glial_cell | 0.50083041 |
| 110 | MP0005535_abnormal_body_temperature | 0.50052355 |
| 111 | MP0001663_abnormal_digestive_system | 0.49948109 |
| 112 | MP0000733_abnormal_muscle_development | 0.49441773 |
| 113 | MP0006054_spinal_hemorrhage | 0.49059561 |
| 114 | MP0008874_decreased_physiological_sensi | 0.48692344 |
| 115 | * MP0009765_abnormal_xenobiotic_induced | 0.48592549 |
| 116 | MP0005376_homeostasis/metabolism_phenot | 0.48294420 |
| 117 | MP0009763_increased_sensitivity_to | 0.47588233 |
| 118 | MP0010678_abnormal_skin_adnexa | 0.47571511 |
| 119 | MP0005171_absent_coat_pigmentation | 0.47328180 |
| 120 | MP0003880_abnormal_central_pattern | 0.46334436 |
| 121 | MP0008961_abnormal_basal_metabolism | 0.45288136 |
| 122 | MP0003943_abnormal_hepatobiliary_system | 0.45059974 |
| 123 | MP0001216_abnormal_epidermal_layer | 0.44585647 |
| 124 | MP0002019_abnormal_tumor_incidence | 0.44516872 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.88511304 |
| 2 | Stomatitis (HP:0010280) | 4.78682656 |
| 3 | Eczematoid dermatitis (HP:0000976) | 4.63042585 |
| 4 | T lymphocytopenia (HP:0005403) | 4.37508725 |
| 5 | Abnormality of T cell number (HP:0011839) | 4.34165718 |
| 6 | Retrobulbar optic neuritis (HP:0100654) | 4.26842349 |
| 7 | Optic neuritis (HP:0100653) | 4.26842349 |
| 8 | Increased IgM level (HP:0003496) | 4.14468216 |
| 9 | Recurrent abscess formation (HP:0002722) | 4.08717422 |
| 10 | Mediastinal lymphadenopathy (HP:0100721) | 4.07914206 |
| 11 | Recurrent fungal infections (HP:0002841) | 4.04708616 |
| 12 | Myositis (HP:0100614) | 3.89392915 |
| 13 | Severe combined immunodeficiency (HP:0004430) | 3.87869063 |
| 14 | Recurrent viral infections (HP:0004429) | 3.82864503 |
| 15 | Orchitis (HP:0100796) | 3.69281218 |
| 16 | Recurrent cutaneous fungal infections (HP:0011370) | 3.61839427 |
| 17 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.61839427 |
| 18 | Vasculitis (HP:0002633) | 3.59626437 |
| 19 | Recurrent bacterial skin infections (HP:0005406) | 3.55920566 |
| 20 | Combined immunodeficiency (HP:0005387) | 3.44511569 |
| 21 | Chronic otitis media (HP:0000389) | 3.43776791 |
| 22 | Pulmonary infiltrates (HP:0002113) | 3.30577171 |
| 23 | Thyroiditis (HP:0100646) | 3.22033533 |
| 24 | Recurrent bronchitis (HP:0002837) | 3.19405365 |
| 25 | Abnormality of T cells (HP:0002843) | 3.18422258 |
| 26 | Chronic obstructive pulmonary disease (HP:0006510) | 3.16499894 |
| 27 | Obstructive lung disease (HP:0006536) | 3.16499894 |
| 28 | Autoimmune hemolytic anemia (HP:0001890) | 3.16323176 |
| 29 | Abnormality of eosinophils (HP:0001879) | 3.12217791 |
| 30 | Autoimmune thrombocytopenia (HP:0001973) | 3.11326006 |
| 31 | Urticaria (HP:0001025) | 3.11010290 |
| 32 | Recurrent skin infections (HP:0001581) | 3.10612243 |
| 33 | Leukocytosis (HP:0001974) | 3.06316894 |
| 34 | Hypergammaglobulinemia (HP:0010702) | 2.99702520 |
| 35 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.96708643 |
| 36 | Eosinophilia (HP:0001880) | 2.96658488 |
| 37 | B lymphocytopenia (HP:0010976) | 2.94411038 |
| 38 | Abnormality of B cell number (HP:0010975) | 2.94411038 |
| 39 | IgG deficiency (HP:0004315) | 2.93616701 |
| 40 | Panhypogammaglobulinemia (HP:0003139) | 2.86815676 |
| 41 | Abnormality of macrophages (HP:0004311) | 2.81926011 |
| 42 | Chronic diarrhea (HP:0002028) | 2.77792343 |
| 43 | Porencephaly (HP:0002132) | 2.75367149 |
| 44 | Hemoptysis (HP:0002105) | 2.75220826 |
| 45 | Gingivitis (HP:0000230) | 2.73815907 |
| 46 | Meningitis (HP:0001287) | 2.67526407 |
| 47 | Agammaglobulinemia (HP:0004432) | 2.65159445 |
| 48 | Anorexia (HP:0002039) | 2.62742798 |
| 49 | Episodic fever (HP:0001954) | 2.61989630 |
| 50 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.53711962 |
| 51 | Lymphopenia (HP:0001888) | 2.52003701 |
| 52 | Abnormality of the fingertips (HP:0001211) | 2.49620022 |
| 53 | Gastrointestinal infarctions (HP:0005244) | 2.49348885 |
| 54 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.48905366 |
| 55 | Peritonitis (HP:0002586) | 2.47071768 |
| 56 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.44374870 |
| 57 | Sepsis (HP:0100806) | 2.42386351 |
| 58 | Keratoconjunctivitis sicca (HP:0001097) | 2.40973824 |
| 59 | Hematochezia (HP:0002573) | 2.40374463 |
| 60 | IgM deficiency (HP:0002850) | 2.39027142 |
| 61 | Thick nail (HP:0001805) | 2.39008736 |
| 62 | Gingival bleeding (HP:0000225) | 2.37991148 |
| 63 | Granulocytopenia (HP:0001913) | 2.36588429 |
| 64 | Alveolar cell carcinoma (HP:0006519) | 2.36416993 |
| 65 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.36340110 |
| 66 | Nasal polyposis (HP:0100582) | 2.28195767 |
| 67 | Slow saccadic eye movements (HP:0000514) | 2.26361417 |
| 68 | Osteomyelitis (HP:0002754) | 2.26280909 |
| 69 | Pustule (HP:0200039) | 2.23565357 |
| 70 | Abnormality of the peritoneum (HP:0002585) | 2.23175614 |
| 71 | Increased IgE level (HP:0003212) | 2.22560071 |
| 72 | Viral hepatitis (HP:0006562) | 2.21601378 |
| 73 | IgA deficiency (HP:0002720) | 2.21381610 |
| 74 | Amyloidosis (HP:0011034) | 2.21011557 |
| 75 | Keratitis (HP:0000491) | 2.20562898 |
| 76 | Inflammation of the large intestine (HP:0002037) | 2.19971124 |
| 77 | Keratoconjunctivitis (HP:0001096) | 2.19128617 |
| 78 | Basal ganglia calcification (HP:0002135) | 2.18797744 |
| 79 | Parakeratosis (HP:0001036) | 2.18046038 |
| 80 | Subacute progressive viral hepatitis (HP:0006572) | 2.17966230 |
| 81 | Arterial thrombosis (HP:0004420) | 2.15169298 |
| 82 | Joint swelling (HP:0001386) | 2.13510503 |
| 83 | Vertigo (HP:0002321) | 2.13139356 |
| 84 | Abnormality of the endocardium (HP:0004306) | 2.11616463 |
| 85 | Polyneuropathy (HP:0001271) | 2.09319032 |
| 86 | Recurrent sinusitis (HP:0011108) | 2.08357880 |
| 87 | Trigonocephaly (HP:0000243) | 2.07801229 |
| 88 | Abnormality of T cell physiology (HP:0011840) | 2.07033310 |
| 89 | Gastrointestinal inflammation (HP:0004386) | 2.04187594 |
| 90 | Glomerulopathy (HP:0100820) | 2.04037525 |
| 91 | Amaurosis fugax (HP:0100576) | 2.02681827 |
| 92 | Prolonged bleeding time (HP:0003010) | 2.01206166 |
| 93 | Encephalitis (HP:0002383) | 2.00241156 |
| 94 | Epistaxis (HP:0000421) | 1.98791642 |
| 95 | Gangrene (HP:0100758) | 1.98179614 |
| 96 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.97239267 |
| 97 | Premature loss of primary teeth (HP:0006323) | 1.96265013 |
| 98 | Thrombophlebitis (HP:0004418) | 1.95849478 |
| 99 | Chest pain (HP:0100749) | 1.93049360 |
| 100 | Colitis (HP:0002583) | 1.91458038 |
| 101 | Chronic sinusitis (HP:0011109) | 1.90336155 |
| 102 | Plagiocephaly (HP:0001357) | 1.90191451 |
| 103 | Gastrointestinal stroma tumor (HP:0100723) | 1.89562544 |
| 104 | Abnormality of the nasal mucosa (HP:0000433) | 1.89114356 |
| 105 | Spontaneous hematomas (HP:0007420) | 1.88030509 |
| 106 | Abnormality of the prostate (HP:0008775) | 1.86841597 |
| 107 | Interstitial pulmonary disease (HP:0006530) | 1.85825025 |
| 108 | Abnormality of the pleura (HP:0002103) | 1.85815871 |
| 109 | Recurrent pneumonia (HP:0006532) | 1.85219085 |
| 110 | Periodontitis (HP:0000704) | 1.83166695 |
| 111 | Bronchitis (HP:0012387) | 1.81350095 |
| 112 | Large earlobe (HP:0009748) | 1.81270655 |
| 113 | Verrucae (HP:0200043) | 1.81154302 |
| 114 | Papilloma (HP:0012740) | 1.81154302 |
| 115 | Abnormality of the nasal septum (HP:0000419) | 1.80361979 |
| 116 | Cheilitis (HP:0100825) | 1.80188508 |
| 117 | Loss of speech (HP:0002371) | 1.79634703 |
| 118 | Arthralgia (HP:0002829) | 1.73887985 |
| 119 | Cleft eyelid (HP:0000625) | 1.72824800 |
| 120 | Abnormality of the pericardium (HP:0001697) | 1.71920443 |
| 121 | Cellulitis (HP:0100658) | 1.71358150 |
| 122 | Adactyly (HP:0009776) | 1.70953614 |
| 123 | Lymphoma (HP:0002665) | 1.70365014 |
| 124 | Depressed nasal tip (HP:0000437) | 1.69688668 |
| 125 | Pulmonary embolism (HP:0002204) | 1.65577666 |
| 126 | Midline defect of the nose (HP:0004122) | 1.65471095 |
| 127 | Absent hand (HP:0004050) | 1.64356955 |
| 128 | Stomach cancer (HP:0012126) | 1.63049065 |
| 129 | Disinhibition (HP:0000734) | 1.62520751 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 4.98551722 |
| 2 | MAP3K14 | 3.63476202 |
| 3 | MAP4K1 | 3.37791068 |
| 4 | SIK3 | 2.90800456 |
| 5 | JAK3 | 2.74860317 |
| 6 | TYK2 | 2.54697646 |
| 7 | EPHA3 | 2.35402363 |
| 8 | * IKBKE | 2.30975359 |
| 9 | BLK | 2.25345194 |
| 10 | MAP2K3 | 2.19519587 |
| 11 | IKBKB | 2.11562639 |
| 12 | ITK | 2.04953477 |
| 13 | FGFR4 | 2.04237959 |
| 14 | ZAP70 | 2.00796730 |
| 15 | MAP3K13 | 1.96743174 |
| 16 | NLK | 1.96684496 |
| 17 | TAOK3 | 1.91257953 |
| 18 | * TBK1 | 1.91065777 |
| 19 | JAK1 | 1.90756080 |
| 20 | MST4 | 1.90134411 |
| 21 | TYRO3 | 1.85800102 |
| 22 | MATK | 1.83157047 |
| 23 | CHUK | 1.80388493 |
| 24 | EPHB1 | 1.70331262 |
| 25 | CSK | 1.68964507 |
| 26 | FGFR3 | 1.61532423 |
| 27 | TAOK1 | 1.53790818 |
| 28 | STK10 | 1.52513607 |
| 29 | PBK | 1.52170219 |
| 30 | LCK | 1.49539272 |
| 31 | IRAK3 | 1.46448169 |
| 32 | MAP3K3 | 1.44881968 |
| 33 | FES | 1.35941749 |
| 34 | MAP3K1 | 1.29317740 |
| 35 | PKN1 | 1.24804486 |
| 36 | TNIK | 1.23368060 |
| 37 | HCK | 1.22605157 |
| 38 | SIK2 | 1.22148075 |
| 39 | MARK3 | 1.21483612 |
| 40 | SYK | 1.21364599 |
| 41 | BMPR2 | 1.20856447 |
| 42 | NUAK1 | 1.20431910 |
| 43 | CLK1 | 1.18978980 |
| 44 | BCR | 1.16585669 |
| 45 | RIPK4 | 1.15115825 |
| 46 | BRD4 | 1.13100121 |
| 47 | BTK | 1.12410525 |
| 48 | TGFBR2 | 1.11835347 |
| 49 | ERN1 | 1.10813583 |
| 50 | PRKCQ | 1.10456087 |
| 51 | FGFR2 | 1.09787015 |
| 52 | KSR2 | 1.09679151 |
| 53 | GRK7 | 1.09605370 |
| 54 | STK24 | 1.07866855 |
| 55 | TNK2 | 1.07075316 |
| 56 | MAP3K11 | 1.03592206 |
| 57 | TAOK2 | 0.97629185 |
| 58 | KIT | 0.97062953 |
| 59 | LYN | 0.92795259 |
| 60 | MAP3K10 | 0.92415793 |
| 61 | SGK2 | 0.90855135 |
| 62 | TEC | 0.90551414 |
| 63 | PDGFRB | 0.88839169 |
| 64 | DYRK2 | 0.87034867 |
| 65 | FGR | 0.86867974 |
| 66 | RPS6KA4 | 0.86184034 |
| 67 | PIM1 | 0.81477274 |
| 68 | JAK2 | 0.80085257 |
| 69 | MAPK7 | 0.79981127 |
| 70 | MAP3K2 | 0.78006459 |
| 71 | MAP3K6 | 0.76631937 |
| 72 | KSR1 | 0.73433957 |
| 73 | SGK3 | 0.71891734 |
| 74 | MAPK13 | 0.71817546 |
| 75 | GRK6 | 0.71496385 |
| 76 | MOS | 0.70079175 |
| 77 | CDK19 | 0.70021277 |
| 78 | EIF2AK2 | 0.66245431 |
| 79 | CDC42BPA | 0.66101254 |
| 80 | BMPR1B | 0.64404760 |
| 81 | RIPK1 | 0.63528006 |
| 82 | TESK2 | 0.62932029 |
| 83 | TLK1 | 0.62005727 |
| 84 | WNK1 | 0.60397923 |
| 85 | YES1 | 0.60325665 |
| 86 | * IRAK1 | 0.58622063 |
| 87 | ERBB3 | 0.58300592 |
| 88 | CASK | 0.58011822 |
| 89 | MAPK15 | 0.57961313 |
| 90 | PDK1 | 0.55381917 |
| 91 | CDK6 | 0.54797689 |
| 92 | ACVR1B | 0.54557664 |
| 93 | RPS6KA5 | 0.54156977 |
| 94 | FYN | 0.54102833 |
| 95 | DYRK3 | 0.52999383 |
| 96 | CSF1R | 0.51367442 |
| 97 | STK4 | 0.50618110 |
| 98 | MELK | 0.50516692 |
| 99 | MARK1 | 0.48963789 |
| 100 | UHMK1 | 0.48322260 |
| 101 | STK11 | 0.47714501 |
| 102 | NTRK2 | 0.47707892 |
| 103 | ABL1 | 0.47655004 |
| 104 | LRRK2 | 0.46346479 |
| 105 | INSRR | 0.46281647 |
| 106 | PIK3CG | 0.46157753 |
| 107 | INSR | 0.46124565 |
| 108 | ERBB2 | 0.44702082 |
| 109 | MARK2 | 0.44628221 |
| 110 | MAP3K5 | 0.44454752 |
| 111 | HIPK2 | 0.43102827 |
| 112 | RAF1 | 0.42840379 |
| 113 | KDR | 0.42578177 |
| 114 | SGK223 | 0.41635478 |
| 115 | SGK494 | 0.41635478 |
| 116 | PRKD2 | 0.39053926 |
| 117 | PASK | 0.38122448 |
| 118 | DYRK1B | 0.37395453 |
| 119 | ICK | 0.35948432 |
| 120 | CSNK1A1L | 0.35269456 |
| 121 | PTK6 | 0.35237651 |
| 122 | MAP2K4 | 0.34771217 |
| 123 | EGFR | 0.34025000 |
| 124 | * IRAK4 | 0.33866953 |
| 125 | MAP3K7 | 0.33222995 |
| 126 | CDK4 | 0.33125387 |
| 127 | CAMK4 | 0.31248216 |
| 128 | PRKCD | 0.30375200 |
| 129 | PRPF4B | 0.29193920 |
| 130 | IGF1R | 0.28105442 |
| 131 | MAPKAPK2 | 0.27450470 |
| 132 | SRPK1 | 0.24716334 |
| 133 | PIM2 | 0.24164205 |
| 134 | FGFR1 | 0.23900942 |
| 135 | STK39 | 0.23065789 |
| 136 | DMPK | 0.21286982 |
| 137 | CDK12 | 0.21137569 |
| 138 | CSNK1G3 | 0.20443999 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.25598859 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 2.98646891 |
| 3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.74791809 |
| 4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.56608682 |
| 5 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.43469981 |
| 6 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.36888863 |
| 7 | Leishmaniasis_Homo sapiens_hsa05140 | 2.36865920 |
| 8 | Measles_Homo sapiens_hsa05162 | 2.32927777 |
| 9 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.16601225 |
| 10 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.11498352 |
| 11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.08577745 |
| 12 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.03998320 |
| 13 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.01878950 |
| 14 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.97292392 |
| 15 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.90251265 |
| 16 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.88026513 |
| 17 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.73717630 |
| 18 | Asthma_Homo sapiens_hsa05310 | 1.73102499 |
| 19 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.62449087 |
| 20 | Viral myocarditis_Homo sapiens_hsa05416 | 1.60742198 |
| 21 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.60737987 |
| 22 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.52216887 |
| 23 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.51422929 |
| 24 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.50881545 |
| 25 | Influenza A_Homo sapiens_hsa05164 | 1.49972387 |
| 26 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.44773810 |
| 27 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.43960317 |
| 28 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.41367037 |
| 29 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.41140634 |
| 30 | Malaria_Homo sapiens_hsa05144 | 1.39714433 |
| 31 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.39708357 |
| 32 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.39091077 |
| 33 | Shigellosis_Homo sapiens_hsa05131 | 1.36114802 |
| 34 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.35065857 |
| 35 | Pertussis_Homo sapiens_hsa05133 | 1.32005691 |
| 36 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.31765880 |
| 37 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.27823418 |
| 38 | Tuberculosis_Homo sapiens_hsa05152 | 1.24527048 |
| 39 | Salmonella infection_Homo sapiens_hsa05132 | 1.23154178 |
| 40 | Legionellosis_Homo sapiens_hsa05134 | 1.20617968 |
| 41 | Hepatitis B_Homo sapiens_hsa05161 | 1.15604379 |
| 42 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.14489136 |
| 43 | Hepatitis C_Homo sapiens_hsa05160 | 1.14203071 |
| 44 | Apoptosis_Homo sapiens_hsa04210 | 1.13440699 |
| 45 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.05864909 |
| 46 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.03587002 |
| 47 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.99961897 |
| 48 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.99185372 |
| 49 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.97336712 |
| 50 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.96482797 |
| 51 | Axon guidance_Homo sapiens_hsa04360 | 0.93778180 |
| 52 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.93729888 |
| 53 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.91358081 |
| 54 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.91175348 |
| 55 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.86362338 |
| 56 | Colorectal cancer_Homo sapiens_hsa05210 | 0.85796144 |
| 57 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.80988760 |
| 58 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.80292022 |
| 59 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.80173093 |
| 60 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.79727488 |
| 61 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.76721959 |
| 62 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.76339183 |
| 63 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.72852591 |
| 64 | HTLV-I infection_Homo sapiens_hsa05166 | 0.71324465 |
| 65 | Platelet activation_Homo sapiens_hsa04611 | 0.71056738 |
| 66 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.68257970 |
| 67 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.62995674 |
| 68 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.62469745 |
| 69 | Prostate cancer_Homo sapiens_hsa05215 | 0.59612828 |
| 70 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.59309141 |
| 71 | Phagosome_Homo sapiens_hsa04145 | 0.58352836 |
| 72 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.57847325 |
| 73 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.54118897 |
| 74 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.53301551 |
| 75 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.52409873 |
| 76 | Other glycan degradation_Homo sapiens_hsa00511 | 0.52341352 |
| 77 | Adherens junction_Homo sapiens_hsa04520 | 0.49705375 |
| 78 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.48097370 |
| 79 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.47450092 |
| 80 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.47171504 |
| 81 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.47152791 |
| 82 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.46689097 |
| 83 | Insulin resistance_Homo sapiens_hsa04931 | 0.46143939 |
| 84 | Endocytosis_Homo sapiens_hsa04144 | 0.46101199 |
| 85 | Endometrial cancer_Homo sapiens_hsa05213 | 0.45242244 |
| 86 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.44758913 |
| 87 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.43836438 |
| 88 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.43570573 |
| 89 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.43363080 |
| 90 | Prion diseases_Homo sapiens_hsa05020 | 0.40566678 |
| 91 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.39782457 |
| 92 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.39668364 |
| 93 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.38922734 |
| 94 | Pathways in cancer_Homo sapiens_hsa05200 | 0.38761545 |
| 95 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.38572954 |
| 96 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.37181793 |
| 97 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.33926228 |
| 98 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.33692195 |
| 99 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.33574297 |
| 100 | Lysosome_Homo sapiens_hsa04142 | 0.33531205 |
| 101 | Amoebiasis_Homo sapiens_hsa05146 | 0.32421007 |
| 102 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.32272011 |
| 103 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.31300928 |
| 104 | Bladder cancer_Homo sapiens_hsa05219 | 0.30802115 |
| 105 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.30700339 |
| 106 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.30550621 |
| 107 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.29625870 |
| 108 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.28439419 |
| 109 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.27945168 |
| 110 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.27658692 |
| 111 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.27428149 |
| 112 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.27159758 |
| 113 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.25333178 |
| 114 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.25021478 |
| 115 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.24055389 |

